A CAR-T therapy given by injection: can it help Hard-to-Treat lymphoma?
Cure
Recruiting now
Researchers are testing a new CAR-T cell therapy called C402-CD19-CAR in adults with large B-cell lymphoma that has come back or stopped responding to treatment. The therapy is made from each participant's own T cells, which are modified to target CD19, a marker on lymphoma cells…
Phase 1 • Sponsor: Shanghai Exuma Biotechnology Ltd. • Aim: Cure
Last updated Sep 13, 2026 00:00 UTC